NEI
GILD icon

Northwest & Ethical Investments’s Gilead Sciences GILD Stock Holding History

Northwest & Ethical Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.4M Buy
346,995
+18,788
+6% +$2.63M 1.12% 15
2025
Q4 		$40.3M Buy
328,207
+9,388
+3% +$1.14M 0.91% 17
2025
Q3 		$35.4M Buy
318,819
+40,568
+15% +$4.61M 0.84% 20
2025
Q2 		$30.8M Sell
278,251
-6,564
-2% -$699K 0.77% 25
2025
Q1 		$31.9M Buy
284,815
+40,620
+17% +$4.19M 0.87% 22
2024
Q4 		$22.6M Buy
244,195
+9,623
+4% +$866K 0.61% 41
2024
Q3 		$19.7M Buy
234,572
+31,746
+16% +$2.42M 0.52% 62
2024
Q2 		$13.9M Sell
202,826
-535
-0.3% -$35.7K 0.4% 82
2024
Q1 		$14.9M Sell
203,361
-35,626
-15% -$2.74M 0.43% 76
2023
Q4 		$19.4M Buy
238,987
+6,139
+3% +$478K 0.59% 50
2023
Q3 		$17.4M Buy
232,848
+46,611
+25% +$3.59M 0.59% 51
2023
Q2 		$14.4M Sell
186,237
-3,391
-2% -$270K 0.46% 70
2023
Q1 		$15.7M Buy
189,628
+126,173
+199% +$10.5M 0.52% 57
2022
Q4 		$5.45M Buy
63,455
+23,902
+60% +$1.89M 0.19% 160
2022
Q3 		$2.44M Sell
39,553
-1,085
-3% -$68.4K 0.1% 218
2022
Q2 		$2.51M Buy
+40,638
New +$2.52M 0.09% 217
2021
Q1 		– Sell
-39,202
Closed -$2.28M – 421
2020
Q4 		$2.28M Hold
39,202
– – 0.09% 238
2020
Q3 		$2.48M Buy
39,202
+23,264
+146% +$1.61M 0.11% 217
2020
Q2 		$1.23M Hold
15,938
– – 0.06% 288
2020
Q1 		$1.19M Hold
15,938
– – 0.07% 272
2019
Q4 		$1.04M Sell
15,938
-37,439
-70% -$2.44M 0.05% 318
2019
Q3 		$3.38M Sell
53,377
-38,690
-42% -$2.53M 0.16% 166
2019
Q2 		$6.22M Buy
92,067
+2,510
+3% +$165K 0.31% 103
2019
Q1 		$5.82M Sell
89,557
-5,050
-5% -$336K 0.3% 106
2018
Q4 		$5.92M Buy
94,607
+42,115
+80% +$2.94M 0.35% 85
2018
Q3 		$4.05M Buy
52,492
+6,630
+14% +$501K 0.25% 125
2018
Q2 		$3.25M Sell
45,862
-48,371
-51% -$3.42M 0.22% 141
2018
Q1 		$7.1M Buy
94,233
+51,281
+119% +$4.08M 0.48% 52
2017
Q4 		$3.08M Sell
42,952
-2,880
-6% -$219K 0.2% 154
2017
Q3 		$3.71M Sell
45,832
-24,574
-35% -$1.88M 0.23% 121
2017
Q2 		$4.98M Buy
70,406
+2,467
+4% +$164K 0.34% 73
2017
Q1 		$4.61M Sell
67,939
-21,309
-24% -$1.5M 0.31% 78
2016
Q4 		$6.39M Sell
89,248
-19,193
-18% -$1.43M 0.44% 48
2016
Q3 		$8.58M Buy
+108,441
New +$8.81M 0.6% 35
2015
Q3 		– Sell
-31,800
Closed -$3.72M – 210
2015
Q2 		$3.72M Buy
31,800
+7,700
+32% +$841K 0.25% 109
2015
Q1 		$2.36M Buy
24,100
+9,700
+67% +$985K 0.17% 140
2014
Q4 		$1.36M Buy
+14,400
New +$1.49M 0.09% 172
2014
Q2 		– Sell
-32,900
Closed -$2.33M – 229
2014
Q1 		$2.33M Hold
32,900
– – 0.15% 152
2013
Q4 		$2.47M Buy
+32,900
New +$2.29M 0.16% 144

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Northwest & Ethical Investments's GILD Position: Q1 2026 in Review

Northwest & Ethical Investments increased its Gilead Sciences (GILD) stake by 5.7% in Q1 2026, buying an estimated $2.63M and bringing the position to 346,995 shares worth $48.4M. The position accounts for 1.12% of the portfolio, ranked #15.

Northwest & Ethical Investments first reported a position in GILD in Q4 2013 and has held it in 39 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Northwest & Ethical Investments held 346,995 shares of Gilead Sciences worth $48.4M as of Q1 2026.
  • Northwest & Ethical Investments bought 18,788 Gilead Sciences shares in Q1 2026, an estimated $2.63M.
  • Gilead Sciences made up 1.12% of Northwest & Ethical Investments's portfolio in Q1 2026, its #15 holding.
  • Northwest & Ethical Investments first reported a position in Gilead Sciences in Q4 2013 and has held it in 39 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Northwest & Ethical Investments's 13F filing for Q1 2026, filed 14 May 2026.